Investors

We are a forward-thinking clinical stage company introducing an innovative solution to control the entire cycle of pain following surgery.

• Gate’s technology combines two clinically proven modalities, sodium channel blockade and neurostimulation into a single platform to address the entire spectrum of pain from the acute neuropathic episode through the weeks of transitional pain following surgery.
• The Gate Keeper phone App puts control of therapy in the hands of the patient and provides entrée into the digital management of pain.
• The technology fits seamlessly into existing clinical routines.
• Our pricing model is an order of magnitude lower than currently available neuromodulation products and is supported by existing surgical procedure codes.

Gate’s approach to pain management differs from all commercially available products and from all other products in development.

Clinical data is imminent.  Want to find out more? Fill out the form below to contact our team.